HomeAgenda
Register
Register
Register

ServiceUpdated on 20 August 2025

PHOENIX SEP: Your Single Entry Point for Nanopharmaceutical Development

About

PHOENIX supports its customers to overcome the "innovation valley of death", enabling transfer of nanopharmaceuticals from lab bench to clinical trials.

PHOENIX provides a Single Entry Point (SEP) for a network of facilities, technologies, services and expertise for all the RDI and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.

Contact us now to see how PHOENIX can help your nanopharmaceutical innovation catch fire!

phoenix-sep.com

Type

  • Development
  • Consulting
  • Manufacturing
  • Others

Applies to

  • Microtechnology
  • Biotech and Lifescience
  • Medtech

Organisation

PHOENIX -OITB gGmbH

Company (SME/startup) / 中小企業・スタートアップ

66802 Überherrn, Germany